Skip to main content

Syquant Capital SAS

SEC CIK
0001766392
Latest filing
Jul 9, 2026

Holdings in Q4 2023

Holdings as of Dec 31, 2023, filed Jan 10, 2024. Long positions only; changes compare share counts with Q3 2023.

Institution overview
Positions
7
−2 vs. Q3 2023
Portfolio value
$22.2M
−$232.5M (−91.3%) vs. Q3 2023
Filed
Jan 10, 2024
SEC
Holdings of Syquant Capital SAS in Q4 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
MRTXMirati Therapeutics, Inc.COM153,920$9.04M40.8%+153,920NewHistory
LAZLazard, Inc.SHS A206,800$7.20M32.5%+206,800NewHistory
ICVXIcosavax, Inc.COM190,654$3.00M13.6%+190,654NewHistory
KRTXKaruna Therapeutics, Inc.COM8,130$2.57M11.6%+8,130NewHistory
LOGILogitech International S.A.SHS1,363$129.0K0.6%+1,363NewHistory
FROFrontline plcCOM6,412$128.0K0.6%+6,412NewHistory
RACEFerrari N.V.COM243$82.0K0.4%+243NewHistory

Sold out since Q3 2023 (9)

Positions held at the end of Q3 2023 that are gone from this filing.

Positions of Syquant Capital SAS sold out since Q3 2023
SecurityClassShares in Q3 2023Value in Q3 2023% of portfolio in Q3 2023History
HZNPHorizon Therapeutics Public Ltd CoSHS1,398,990$161.8M63.5%History
ATVIActivision Blizzard, Inc.COM763,211$71.5M28.1%History
TWNKHostess Brands, Inc.CL A183,050$6.10M2.4%History
CPRICapri Holdings LtdSHS113,582$5.98M2.3%History
NATINational Instruments CorpCOM53,300$3.18M1.2%History
SGENSeagen Inc.COM14,000$2.19M0.9%History
Intercept Pharmaceuticals IN45845PAB4NOTE 2.000% 5/1–$1.96M0.8%–
ARMKAramarkCOM34,267$1.19M0.5%History
PHINPhinia Inc.COMMON STOCK29,599$793.0K0.3%History